IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories shares outstanding 1991–2026

IDEXX Laboratories had 78,786,263 shares outstanding on 12 November 2026. IDEXX Laboratories had 79.80M diluted shares on average over the last twelve months, down 2.1% on the twelve months before. In fiscal year 2025 the average was 80.68M.

Last updated 7 Nov 2026 · Next report 1 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 202679.80M-2.13%79.78M
FY202531 Dec 202580.68M-3.09%80.10M
FY202431 Dec 202483.25M-0.87%82.47M
FY202331 Dec 202383.98M-0.74%83.07M
FY202231 Dec 202284.60M-2.28%83.62M
FY202131 Dec 202186.57M-0.17%85.20M
FY202031 Dec 202086.72M-0.94%85.34M
FY201931 Dec 201987.54M-1.05%86.12M
FY201831 Dec 201888.47M-1.22%86.86M
FY201731 Dec 201789.57M-1.45%87.77M
FY201631 Dec 201690.88M-2.95%89.73M
FY201531 Dec 201593.65M-7.74%92.60M
FY201431 Dec 2014101.50M-5.99%100.09M
FY201331 Dec 2013107.97M-3.86%106.32M
FY201231 Dec 2012112.31M-3.54%109.97M
FY201131 Dec 2011116.43M-2.26%113.58M
FY201031 Dec 2010119.12M-1.85%115.43M
FY200931 Dec 2009121.36M-2.52%117.62M
FY200831 Dec 2008124.50M-3.42%119.91M
FY200731 Dec 2007128.91M-2.20%123.12M
FY200631 Dec 2006131.81M-3.23%125.73M
FY200531 Dec 2005136.22M-4.87%130.08M
FY200431 Dec 2004143.20M-0.36%136.86M
FY200331 Dec 2003143.72M+2.53%137.08M
FY200231 Dec 2002140.17M+1.16%134.49M
FY200131 Dec 2001138.56M-3.99%133.17M
FY200031 Dec 2000144.32M-9.24%138.30M
FY199931 Dec 1999159.02M+4.62%153.41M
FY199831 Dec 1998152.00M+0.85%152.00M
FY199731 Dec 1997150.71M-4.07%150.71M
FY199631 Dec 1996157.11M+11.44%148.18M
FY199531 Dec 1995140.98M+6.00%132.31M
FY199431 Dec 1994133.00M-0.59%126.67M
FY199331 Dec 1993133.79M+25.43%125.16M
FY199231 Dec 1992106.67M+33.33%106.67M
FY199131 Dec 199180.00M—80.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about IDEXX Laboratories's shares

Source: Financial Modeling Prep